<html><head><link rel="stylesheet" type="text/css" href="usc.css"/><title>U.S.C. Title 21 - FOOD AND DRUGS</title></head><body>
<span style="font-weight:bold;font-size:12pt;">21 U.S.C. </span><br/>
<span style="font-size:10pt">United States Code, 1994 Edition</span><br/>
<span style="font-size:10pt">Title 21 - FOOD AND DRUGS</span><br/>
<span style="font-size:10pt">CHAPTER 12 - MEAT INSPECTION</span><br/>
<span style="font-size:10pt">SUBCHAPTER I_2 - SUBCHAPTER I-CONTROL AND ENFORCEMENT</span><br/>
<span style="font-size:10pt">Part C - Registration of Manufacturers, Distributors, and Dispensers of Controlled Substances</span><br/>
<span style="font-size:10pt">Sec. 827 - Records and reports of registrants</span><br/>
<span style="font-size:10pt">From the U.S. Government Printing Office, <a href="http://www.gpo.gov">www.gpo.gov</a></span><br/><br/>
<!-- documentid:21_827  usckey:210000000082700000000000000000000 currentthrough:19950104 documentPDFPage:292 -->
<!-- itempath:/210/CHAPTER 12/SUBCHAPTER I_2/Part C/Sec. 827 -->
<!-- itemsortkey:210AAOU -->
<!-- expcite:TITLE 21-FOOD AND DRUGS!@!CHAPTER 12-MEAT INSPECTION!@!SUBCHAPTER I-CONTROL AND ENFORCEMENT!@!Part C-Registration of Manufacturers, Distributors, and Dispensers of Controlled Substances!@!Sec. 827 -->
<!-- field-start:head -->
<h3 class="section-head">&sect;827. Records and reports of registrants</h3>
<!-- field-end:head -->
<!-- field-start:statute -->
<h4 class="subsection-head">(a) Inventory</h4>
<p class="statutory-body">Except as provided in subsection (c) of this section&mdash;</p>
<p class="statutory-body-1em">(1) every registrant under this subchapter shall, on May 1, 1971, or as soon thereafter as such registrant first engages in the manufacture, distribution, or dispensing of controlled substances, and every second year thereafter, make a complete and accurate record of all stocks thereof on hand, except that the regulations prescribed under this section shall permit each such biennial inventory (following the initial inventory required by this paragraph) to be prepared on such registrant's regular general physical inventory date (if any) which is nearest to and does not vary by more than six months from the biennial date that would otherwise apply;</p>
<p class="statutory-body-1em">(2) on the effective date of each regulation of the Attorney General controlling a substance that immediately prior to such date was not a controlled substance, each registrant under this subchapter manufacturing, distributing, or dispensing such substance shall make a complete and accurate record of all stocks thereof on hand; and</p>
<p class="statutory-body-1em">(3) on and after May 1, 1971, every registrant under this subchapter manufacturing, distributing, or dispensing a controlled substance or substances shall maintain, on a current basis, a complete and accurate record of each such substance manufactured, received, sold, delivered, or otherwise disposed of by him, except that this paragraph shall not require the maintenance of a perpetual inventory.</p>
<h4 class="subsection-head">(b) Availability of records</h4>
<p class="statutory-body">Every inventory or other record required under this section (1) shall be in accordance with, and contain such relevant information as may be required by, regulations of the Attorney General, (2) shall (A) be maintained separately from all other records of the registrant, or (B) alternatively, in the case of nonnarcotic controlled substances, be in such form that information required by the Attorney General is readily retrievable from the ordinary business records of the registrant, and (3) shall be kept and be available, for at least two years, for inspection and copying by officers or employees of the United States authorized by the Attorney General.</p>
<h4 class="subsection-head">(c) Nonapplicability</h4>
<p class="statutory-body">The foregoing provisions of this section shall not apply&mdash;</p>
<p class="statutory-body-1em">(1)(A) to the prescribing of controlled substances in schedule II, III, IV, or V by practitioners acting in the lawful course of their professional practice unless such substance is prescribed in the course of maintenance or detoxification treatment of an individual; or</p>
<p class="statutory-body-1em">(B) to the administering of a controlled substance in schedule II, III, IV, or V unless the practitioner regularly engages in the dispensing or administering of controlled substances and charges his patients, either separately or together with charges for other professional services, for substances so dispensed or administered or unless such substance is administered in the course of maintenance treatment or detoxification treatment of an individual;</p>
<p class="statutory-body-1em">(2)(A) to the use of controlled substances, at establishments registered under this subchapter which keep records with respect to such substances, in research conducted in conformity with an exemption granted under section 355(i) or 360b(j) of this title;</p>
<p class="statutory-body-1em">(B) to the use of controlled substances, at establishments registered under this subchapter which keep records with respect to such substances, in preclinical research or in teaching; or</p>
<p class="statutory-body-1em">(3) to the extent of any exemption granted to any person, with respect to all or part of such provisions, by the Attorney General by or pursuant to regulation on the basis of a finding that the application of such provisions (or part thereof) to such person is not necessary for carrying out the purposes of this subchapter.</p>
<br class="Q04" />
<p class="statutory-body-block">Nothing in the Convention on Psychotropic Substances shall be construed as superseding or <!-- PDFPage:293 -->otherwise affecting the provisions of paragraph (1)(B), (2), or (3) of this subsection.</p>
<h4 class="subsection-head">(d) Periodic reports to Attorney General</h4>
<p class="statutory-body">Every manufacturer registered under section 823 of this title shall, at such time or times and in such form as the Attorney General may require, make periodic reports to the Attorney General of every sale, delivery or other disposal by him of any controlled substance, and each distributor shall make such reports with respect to narcotic controlled substances, identifying by the registration number assigned under this subchapter the person or establishment (unless exempt from registration under section 822(d) of this title) to whom such sale, delivery, or other disposal was made.</p>
<h4 class="subsection-head">(e) Reporting and recordkeeping requirements of drug conventions</h4>
<p class="statutory-body">In addition to the reporting and recordkeeping requirements under any other provision of this subchapter, each manufacturer registered under section 823 of this title shall, with respect to narcotic and nonnarcotic controlled substances manufactured by it, make such reports to the Attorney General, and maintain such records, as the Attorney General may require to enable the United States to meet its obligations under articles 19 and 20 of the Single Convention on Narcotic Drugs and article 16 of the Convention on Psychotropic Substances. The Attorney General shall administer the requirements of this subsection in such a manner as to avoid the unnecessary imposition of duplicative requirements under this subchapter on manufacturers subject to the requirements of this subsection.</p>
<h4 class="subsection-head">(f) Investigational uses of drugs; procedures</h4>
<p class="statutory-body">Regulations under sections 355(i) and 360(j) of this title, relating to investigational use of drugs, shall include such procedures as the Secretary, after consultation with the Attorney General, determines are necessary to insure the security and accountability of controlled substances used in research to which such regulations apply.</p>
<h4 class="subsection-head">(g) Change of address</h4>
<p class="statutory-body">Every registrant under this subchapter shall be required to report any change of professional or business address in such manner as the Attorney General shall by regulation require.</p>
<!-- field-end:statute -->
<!-- field-start:sourcecredit -->
<p class="source-credit">(Pub. L. 91&ndash;513, title II, &sect;307, Oct. 27, 1970, 84 Stat. 1258; Pub. L. 93&ndash;281, &sect;5, May 14, 1974, 88 Stat. 125; Pub. L. 95&ndash;633, title I, &sect;&sect;104, 110, Nov. 10, 1978, 92 Stat. 3772, 3773; Pub. L. 98&ndash;473, title II, &sect;&sect;514, 515, Oct. 12, 1984, 98 Stat. 2074.)</p>
<!-- field-end:sourcecredit -->
<!-- field-start:notes -->
<!-- field-start:referenceintext-note -->
<h4 class="note-head">References in Text</h4>
<p class="note-body">Schedules II, III, IV, and V, referred to in subsec. (c), are set out in section 812(c) of this title.</p>
<!-- field-end:referenceintext-note -->
<!-- field-start:amendment-note -->
<h4 class="note-head">Amendments</h4>
<p class="note-body">1984&mdash;Subsec. (c)(1)(A). Pub. L. 98&ndash;473, &sect;514(a), substituted &ldquo;to the prescribing of controlled substances in schedule II, III, IV, or V by practitioners acting in the lawful course of their professional practice unless such substance is prescribed in the course of maintenance or detoxification treatment of an individual&rdquo; for &ldquo;with respect to any narcotic controlled substance in schedule II, III, IV, or V, to the prescribing or administering of such substance by a practitioner in the lawful course of his professional practice unless such substance was prescribed or administered in the course of maintenance treatment or detoxification treatment of an individual&rdquo;.</p>
<p class="note-body">Subsec. (c)(1)(B). Pub. L. 98&ndash;473, &sect;514(b), substituted &ldquo;to the administering of a controlled substance in schedule II, III, IV, or V unless the practitioner regularly engages in the dispensing or administering of controlled substances and charges his patients, either separately or together with charges for other professional services, for substances so dispensed or administered or unless such substance is administered in the course of maintenance treatment or detoxification treatment of an individual&rdquo; for &ldquo;with respect to nonnarcotic controlled substances in schedule II, III, IV, or V, to any practitioner who dispenses such substances to his patients, unless the practitioner is regularly engaged in charging his patients, either separately or together with charges for other professional services, for substances so dispensed&rdquo;.</p>
<p class="note-body">Subsec. (g). Pub. L. 98&ndash;473, &sect;515, added subsec. (g).</p>
<p class="note-body">1978&mdash;Subsec. (c). Pub. L. 95&ndash;633, &sect;110, inserted provision following par. (3) relating to the construction of the Convention on Psychotropic Substances.</p>
<p class="note-body">Subsecs. (e), (f). Pub. L. 95&ndash;633 added subsec. (e) and redesignated former subsec. (e) as (f).</p>
<p class="note-body">1974&mdash;Subsec. (c)(1)(A). Pub. L. 93&ndash;281 substituted &ldquo;any narcotic controlled substance&rdquo; for &ldquo;narcotic controlled substances&rdquo; and made section applicable to any narcotic controlled substance prescribed or administered in the course of maintenance treatment or detoxification treatment of an individual.</p>
<!-- field-end:amendment-note -->
<!-- field-start:effectivedate-amendment-note -->
<h4 class="note-head">Effective Date of 1978 Amendment</h4>
<p class="note-body">Amendment by Pub. L. 95&ndash;633 effective on date the Convention on Psychotropic Substances enters into force in the United States [July 15, 1980], see section 112 of Pub. L. 95&ndash;633, set out as an Effective Date note under section 801a of this title.</p>
<!-- field-end:effectivedate-amendment-note -->
<!-- field-end:notes -->
<!-- field-start:secref -->
<h4 class="note-head">Section Referred to in Other Sections</h4>
<!-- field-end:secref -->
<!-- field-start:sectionreferredto -->
<p class="note-body">This section is referred to in sections 823, 829, 902, 958 of this title.</p>
<!-- field-end:sectionreferredto -->


</body></html>